UCB's Zogenix Bet Pays Out Quickly With Fresh Fintepla Approval

Second Indication For Rare Epilepsy Potential Blockbuster

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.